1,181
Views
4
CrossRef citations to date
0
Altmetric
Original Contributions

Survival in Patients with Paramedic-Identified ST-Segment Elevation Myocardial Infarction

Pages 487-495 | Received 04 Jun 2020, Accepted 07 Aug 2020, Published online: 05 Oct 2020

References

  • Langabeer JR, 2nd, Dellifraine J, Fowler R, Jollis JG, Stuart L, Segrest W, Griffin R, Koenig W, Moyer P, Henry TD. Emergency medical services as a strategy for improving ST-elevation myocardial infarction system treatment times. J Emerg Med. 2014;46(3):355–62. doi:10.1016/j.jemermed.2013.08.112.
  • Mannsverk J, Steigen T, Wang H, Tande PM, Dahle BM, Nedrejord ML, Hokland IO, Gilbert M. Trends in clinical outcomes and survival following prehospital thrombolytic therapy given by ambulance clinicians for ST-elevation myocardial infarction in rural sub-arctic Norway. Eur Heart J Acute Cardiovasc Care. 2019;8(1):8–14. doi:10.1177/2048872617748550.
  • García-García C, Ribas N, Recasens LL, Meroño O, Subirana I, Fernández A, Pérez A, Miranda F, Tizón-Marcos H, Martí-Almor J, et al. In-hospital prognosis and long-term mortality of STEMI in a reperfusion network. "Head to head" analisys: invasive reperfusion vs optimal medical therapy. BMC Cardiovasc Disord. 2017;17(1):139. doi:10.1186/s12872-017-0574-6.
  • Brieger DB, Chew DPB, Redfern J, Ellis C, Briffa TG, Howell TE, Aliprandi-Costa B, Astley CM, Gamble G, Carr B, et al. Survival after an acute coronary syndrome: 18-month outcomes from the Australian and New Zealand SNAPSHOT ACS study. Med J Aust. 2015;203(9):368. doi:10.5694/mja15.00504.
  • Vernon ST, Coffey S, D'Souza M, Chow CK, Kilian J, Hyun K, Shaw JA, Adams M, Roberts-Thomson P, Brieger D, et al. ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes? J Am Heart Assoc. 2019;8(21):e013296. doi:10.1161/JAHA.119.013296.
  • Zandecki L, Sadowski M, Janion M, Gierlotka M, Gasior M, Polonski L. Trends in sex differences in clinical characteristics, treatment strategies, and mortality in patients with ST-elevation myocardial infarction in Poland from 2005 to 2011. Coron Artery Dis. 2017;28(5):417–25. doi:10.1097/MCA.0000000000000504.
  • Almawiri A, Jan V, Ziad A, Martin J, Josef S. Mortality benefit of primary transportation to a PCI-capable center persists through an eight-year follow-up in patients with ST-segment elevation myocardial infarction. J Interven Cardiol. 2017;30(6):522–26. doi:10.1111/joic.12419.
  • Australian Bureau of Statistics. Census data 2011. Accessed 22 March 2020. http://abs.gov.au/websitedbs/censushome.nsf/home/historicaldata2011?opendocument&navpos=280.
  • Doan TN, Schultz BV, Rashford S, Rogers B, Prior M, Vollbon W, Bosley E. Prehospital ST-segment elevation myocardial infarction (STEMI) in Queensland, Australia: findings from 11 years of the statewide prehospital reperfusion strategy. Prehosp Emerg Care. 2020;24(3):326–34. doi:10.1080/10903127.2019.1651433.
  • Queensland Government. Thrombolysis for STEMI clinical pathway. 2017. Accessed 30 March 2020. https://www.health.qld.gov.au/__data/assets/pdf_file/0022/437134/sw547-stemi-pathway.pdf.
  • Vanezis AP, Arnold JR, Rodrigo G, Lai FY, Debiec R, Nazir S, Khan JN, Ng LL, Chitkara K, Coghlan JG, et al. Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial. Heart. 2018;104(23):1955–62. doi:10.1136/heartjnl-2018-313091.
  • Kidney Health Australia. Fact sheet estimated glomerular filtration rate (eGFR). 2017. Accessed 30 March 2020. https://kidney.org.au/cms_uploads/docs/egfr-fact-sheet.pdf.
  • Australian Government Department of Health. Body mass index (BMI). 2020. Accessed 30 March 2020. http://healthyweight.health.gov.au/wps/portal/Home/get-started/are-you-a-healthy-weight/bmi/.
  • Auffret V, Leurent G, Boulmier D, Bedossa M, Zabalawi A, Hacot J-P, Coudert I, Filippi E, Castellant P, Rialan A, et al. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: insights from the ORBI registry. Arch Cardiovasc Dis. 2016;109(12):696–707. doi:10.1016/j.acvd.2015.10.007.
  • Margolis G, Letourneau-Shesaf S, Khoury S, Pereg D, Kofman N, Keren G, Shacham Y. Trends and predictors of prehospital delay in patients undergoing primary coronary intervention. Coron Artery Dis. 2018;29(5):373–77. doi:10.1097/MCA.0000000000000608.
  • Honaker J, King G, Blackwell M. AMELIA II: a program for missing data. 2019. https://cran.r-project.org/web/packages/Amelia/vignettes/amelia.pdf.
  • Khan AA, Fletcher PJ, Boyle AJ. Pre-hospital thrombolysis in ST-segment elevation myocardial infarction: a regional Australian experience. Med J Aust. 2017;206(8):369–70. doi:10.5694/mja16.01260.
  • Davis P, Howie GJ, Dicker B, Garrett NK. Paramedic-delivered fibrinolysis in the treatment of ST-elevation myocardial infarction: comparison of a physician-authorized versus autonomous paramedic approach. Prehosp Emerg Care. 2020;24(5):617–24. doi: 10.1080/10903127.2019.1683661.
  • Björklund E, Stenestrand U, Lindbäck J, Svensson L, Wallentin L, Lindahl B. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J. 2006;27(10):1146–52. doi:10.1093/eurheartj/ehi886.
  • Lavie CJ, Oktay AA, Milani RV. The obesity paradox and obesity severity in elderly STEMI patients. Eur Heart J Qual Care Clin Outcomes. 2017;3(3):166–7. doi:10.1093/ehjqcco/qcx018.
  • Bucholz EM, Beckman AL, Krumholz HA, Krumholz HM. Excess weight and life expectancy after acute myocardial infarction: the obesity paradox reexamined. Am Heart J. 2016;172:173–81. doi:10.1016/j.ahj.2015.10.024.
  • Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the get with the guidelines database. Am J Cardiol. 2007;100(9):1331–35. doi:10.1016/j.amjcard.2007.06.019.
  • Cepeda-Valery B, Chaudhry K, Slipczuk L, Pressman GS, Figueredo VM, Lavie CJ, Morris DL, Romero-Corral A. Association between obesity and severity of coronary artery disease at the time of acute myocardial infarction: another piece of the puzzle in the "obesity paradox". Int J Cardiol. 2014;176(1):247–49. doi:10.1016/j.ijcard.2014.06.061.
  • Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, IABP-SHOCK II Trial Investigators, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–96. doi:10.1056/NEJMoa1208410.
  • Vergara R, Valenti R, Migliorini A, Cerisano G, Carrabba N, Giurlani L, Antoniucci D. A new risk score to predict long-term cardiac mortality in patients with acute myocardial infarction complicated by cardiogenic shock and treated with primary percutaneous intervention. Am J Cardiol. 2017;119(3):351–4. doi:10.1016/j.amjcard.2016.10.034.
  • Homorodean C, Iancu AC, Dregoesc IM, Spînu M, Ober MC, Tãtaru D, Leucuţa D, Olinic M, Olinic DM. Renal failure impact on the outcomes of ST-segment elevation myocardial infarction patients due to a left main coronary culprit lesion treated using a primary percutaneous coronary intervention. JCM. 2019;8(4):565. doi:10.3390/jcm8040565.
  • Coory MD, Walsh WF. Rates of percutaneous coronary interventions and bypass surgery after acute myocardial infarction in Indigenous patients. Med J Aust. 2005;182(10):507–12.
  • Randall DA, Jorm LR, Lujic S, O'Loughlin AJ, Churches TR, Haines MM, Eades SJ, Leyland AH. Mortality after admission for acute myocardial infarction in Aboriginal and non-Aboriginal people in New South Wales, Australia: a multilevel data linkage study. BMC Public Health. 2012;12:281. doi:10.1186/1471-2458-12-281.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.